TBIO
$23.33
Translate Bio
($.03)
(.13%)
TBIO
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  ($0.30)
Revenue:  $17.80 Mil
Thursday
Feb 4
4:20 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when TBIO reports earnings?
Beat
Meet
Miss

Where is TBIO's stock price going from here?
Up
Flat
Down
Stock chart of TBIO
Analysts
Summary of analysts' recommendations for TBIO
Score
Grade
Pivots
Resistance
$25.53
$24.80
$24.07

$23.34

Support
$22.61
$21.88
$21.15
Tweet
Growth
Description
Translate Bio, Inc. operates as a therapeutics company. It develops transformative medicines for the treatment of diseases caused by protein and gene dysfunction. Translate Bio, Inc. is based in MA, United States.
Peers
IlluminaAgilent TechnologiesPerkinElmerCoherentHarvard BioscienceBio-Rad Laboratories